Tilray anticipates $150M global medical cannabis revenue run rate as international expansion accelerates (NASDAQ:TLRY)
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]